AstraZeneca PLCAZNNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -52.67% |
| Q3 2025 | 51.62% |
| Q2 2025 | -8.81% |
| Q1 2025 | 27.73% |
| Q4 2024 | -14.07% |
| Q3 2024 | 9.66% |
| Q2 2024 | 24.09% |
| Q1 2024 | 4.45% |
| Q4 2023 | -23.57% |
| Q3 2023 | 81.26% |
| Q2 2023 | -45.16% |
| Q1 2023 | 30.65% |
| Q4 2022 | -18.16% |
| Q3 2022 | 134.78% |
| Q2 2022 | -61.39% |
| Q1 2022 | 127.93% |
| Q4 2021 | -17.51% |
| Q3 2021 | 92.71% |
| Q2 2021 | -53.88% |
| Q1 2021 | 7.56% |
| Q4 2020 | -1.32% |
| Q3 2020 | 75.19% |
| Q2 2020 | 648.20% |
| Q1 2020 | -89.89% |
| Q4 2019 | 24.66% |
| Q3 2019 | 25.63% |
| Q2 2019 | 326.87% |
| Q1 2019 | -117.40% |
| Q4 2018 | 374.20% |
| Q3 2018 | 621.54% |
| Q2 2018 | 146.43% |
| Q1 2018 | -114.04% |
| Q4 2017 | -55.55% |
| Q3 2017 | 797.20% |
| Q2 2017 | 184.09% |
| Q1 2017 | -95.51% |
| Q4 2016 | 141.68% |
| Q3 2016 | 348.07% |
| Q2 2016 | -84.83% |
| Q1 2016 | 108.93% |